Ligand Pharmaceuticals
Earnings Surprise
Analysts estimated LGND earnings of $1.59 per share this quarter (Q4). LGND's actual earnings were $2.02 per share.
LGND EPS surprise of 26.84%Analysts estimated LGND earnings of $1.96 per share this quarter (Q3). LGND's actual earnings were $3.09 per share.
LGND EPS surprise of 57.32%Analysts estimated LGND earnings of $1.45 per share this quarter (Q2). LGND's actual earnings were $1.60 per share.
LGND EPS surprise of 10.35%Analysts estimated LGND earnings of $1.24 per share this quarter (Q1). LGND's actual earnings were $1.33 per share.
LGND EPS surprise of 7.61%Analysts estimated LGND earnings of $1.21 per share this quarter (Q4). LGND's actual earnings were $-1.64 per share.
LGND EPS surprise of -174.01%Analysts estimated LGND earnings of $1.37 per share this quarter (Q3). LGND's actual earnings were $1.84 per share.
LGND EPS surprise of 33.97%Analysts estimated LGND earnings of $1.08 per share this quarter (Q2). LGND's actual earnings were $1.40 per share.
LGND EPS surprise of 29.98%Analysts estimated LGND earnings of $0.79 per share this quarter (Q1). LGND's actual earnings were $1.20 per share.
LGND EPS surprise of 50.98%Analysts estimated LGND earnings of $0.67 per share this quarter (Q4). LGND's actual earnings were $1.05 per share.
LGND EPS surprise of 55.79%